The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Open accessAbstract
The p53 pro-apoptotic tumour suppressor is mutated or functionally altered in most cancers. In epithelial tumours induced by ‘high-risk’ mucosal human papilloma viruses, including human cervical carcinoma and a growing number of head-and-neck cancers, p53 is degraded by the viral oncoprotein E6 (ref. 2). In this process, E6 binds to a short leucine (L)-rich LxxLL consensus sequence within the cellular ubiquitin ligase E6AP. Subsequently, the E6/E6AP heterodimer recruits and degrades p53 (ref. 4). Neither E6 nor E6AP are separately able to recruit p53 (refs 3, 5), and the precise mode of assembly of E6, E6AP and p53 is unknown. Here we solve the crystal structure of a ternary complex comprising full-length human papilloma virus type 16 (HPV-16) E6, the LxxLL motif of E6AP and the core domain of p53. The LxxLL motif of E6AP renders the conformation of E6 competent for interaction with p53 by structuring a p53-binding cleft on E6. Mutagenesis of critical positions at the E6–p53 interface disrupts p53 degradation. The E6-binding site of p53 is distal from previously described DNA- and protein-binding surfaces of the core domain. This suggests that, in principle, E6 may avoid competition with cellular factors by targeting both free and bound p53 molecules. The E6/E6AP/p53 complex represents a prototype of viral hijacking of both the ubiquitin-mediated protein degradation pathway and the p53 tumour suppressor pathway. The present structure provides a framework for the design of inhibitory therapeutic strategies against oncogenesis mediated by human papilloma virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The p53-DBD is also targeted by viral oncoproteins, such as the large T antigen (LTag) of simian virus 40 (SV40)310 (Fig. 7h) and human papillomavirus (HPV) oncoprotein E6311,312 (Fig. 7i).”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [311]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade
Scheffner, M., Nuber, U., & Huibregtse, J. M. (1995) · Nature · doi:10.1038/373081a0 · Cited by 1,016
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A.-B., Gillison, M. L., Doorbar, J., Stern, P. L., Stanley, M., Arbyn, M., Poljak, M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.026 · Cited by 433
How viruses hijack cell regulation
Davey, N. E., Travé, G., & Gibson, T. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.10.002 · Cited by 393
Self-citationPapillomavirus E6 oncoproteins
Vande Pol, S. B., & Klingelhutz, A. J. (2013) · Virology · doi:10.1016/j.virol.2013.04.026 · Cited by 346
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A.-B., Gillison, M. L., Doorbar, J., Stern, P. L., Stanley, M., Arbyn, M., Poljak, M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.003 · Cited by 328
Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins
Zanier, K., Charbonnier, S., Sidi, A. O. M. O., McEwen, A. G., Ferrario, M. G., Poussin-Courmontagne, P., Cura, V., Brimer, N., Babah, K. O., Ansari, T., et al. (2013) · Science · doi:10.1126/science.1229934 · Cited by 222
Self-citationHengstermann, A., Linares, L. K., Ciechanover, A., Whitaker, N. J., & Scheffner, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1218 · Cited by 209
Li, X., & Coffino, P. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4509-4516.1996 · Cited by 201
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4918 · Cited by 182
Benchmarking a luciferase complementation assay for detecting protein complexes
Cassonnet, P., Rolloy, C., Neveu, G., Vidalain, P.-O., Chantier, T., Pellet, J., Jones, L., Muller, M., Demeret, C., Gaud, G., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1773 · Cited by 169
Liu, Y., Chen, J. J., Gao, Q., Dalal, S., Hong, Y., Mansur, C. P., Band, V., & Androphy, E. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7297-7307.1999 · Cited by 165
Foster, S. A., Demers, G. W., Etscheid, B. G., & Galloway, D. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5698-5705.1994 · Cited by 160
Moon, A. F., Mueller, G. A., Zhong, X., & Pedersen, L. C. (2010) · Protein Science · doi:10.1002/pro.368 · Cited by 148
Scheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D., & Howley, P. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.5100-5105.1992 · Cited by 146
Lilyestrom, W., Klein, M. G., Zhang, R., Joachimiak, A., & Chen, X. S. (2006) · Genes & Development · doi:10.1101/gad.1456306 · Cited by 132
Zanier, K., ould M'hamed ould Sidi, A., Boulade-Ladame, C., Rybin, V., Chappelle, A., Atkinson, A., Kieffer, B., & Travé, G. (2012) · Structure · doi:10.1016/j.str.2012.02.001 · Cited by 125
Self-citationMésplède, T., Gagnon, D., Bergeron-Labrecque, F., Azar, I. H., Sénéchal, H., Coutlée, F., & Archambault, J. (2011) · Journal of Virology · doi:10.1128/jvi.00751-11 · Cited by 110
Cherry, J. J., Rietz, A., Malinkevich, A., Liu, Y., Xie, M., Bartolowits, M. D., Davisson, V. J., Baleja, J., & Androphy, E. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084506 · Cited by 97
Structure of the human p53 core domain in the absence of DNA
Wang, Y., Rosengarth, A., & Luecke, H. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906048499 · Cited by 97
Hiller, T., Poppelreuther, S., Stubenrauch, F., & Iftner, T. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0778 · Cited by 96
Cooper, B., Schneider, S., Bohl, J., Jiang, Y.-H., Beaudet, A. L., & Pol, S. V. (2003) · Virology · doi:10.1016/s0042-6822(02)00012-0 · Cited by 94
Self-citationIdentification and Characterization of Small Molecule Human Papillomavirus E6 Inhibitors
Malecka, K. A., Fera, D., Schultz, D., Hodawadekar, S. C., Reichman, M., Donover, P. S., Murphy, M. E., & Marmorstein, R. (2014) · ACS Chemical Biology · doi:10.1021/cb500229d · Cited by 79
The Active Form of E6-associated protein (E6AP)/UBE3A Ubiquitin Ligase Is an Oligomer
Ronchi, V. P., Klein, J. M., Edwards, D. J., & Haas, A. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517805 · Cited by 75
Fu, L., Doorslaer, K. V., Chen, Z., Ristriani, T., Masson, M., Travé, G., & Burk, R. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012816 · Cited by 73
Self-citationBernard, X., Robinson, P., Nominé, Y., Masson, M., Charbonnier, S., Ramirez-Ramos, J. R., Deryckère, F., Travé, G., & Orfanoudakis, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025981 · Cited by 71
Self-citationZanier, K., Stutz, C., Kintscher, S., Reinz, E., Sehr, P. A., Bulkescher, J., Hoppe‐Seyler, K., Travé, G., & Hoppe‐Seyler, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112514 · Cited by 67
Self-citationNakagawa, S., Watanabe, S., Yoshikawa, H., Taketani, Y., Yoshiike, K., & Kanda, T. (1995) · Virology · doi:10.1006/viro.1995.1511 · Cited by 67
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A., Gillison, M. L., Doorbar, J., Stern, P. L., Stanley, M., Arbyn, M., Poljak, M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.002 · Cited by 66
Peptide Interactions Stabilize and Restructure Human Papillomavirus Type 16 E6 To Interact with p53
Ansari, T., Brimer, N., & Pol, S. V. (2012) · Journal of Virology · doi:10.1128/jvi.01236-12 · Cited by 51
Self-citationRistriani, T., Fournane, S., Orfanoudakis, G., Travé, G., & Masson, M. (2008) · Oncogene · doi:10.1038/onc.2008.422 · Cited by 49
Self-citationStutz, C., Reinz, E., Honegger, A., Bulkescher, J., Schweizer, J., Zanier, K., Travé, G., Lohrey, C., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132339 · Cited by 21
Self-citationGu, J., Rubin, R. M., & Yuan, Z.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204454 · Cited by 19
Cited by
PROTAC targeted protein degraders: the past is prologue
Békés, M., Langley, D. R., & Crews, C. M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00371-6 · Cited by 3,395
Ubiquitin ligases: structure, function, and regulation
Zheng, N., & Shabek, N. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014922 · Cited by 1,499
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng, F., Liao, M., Qin, R., Zhu, S., Peng, C., Fu, L., Chen, Y., & Han, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01110-y · Cited by 832
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Hoppe-Seyler, K., Bossler, F., Braun, J. A., Herrmann, A. L., & Hoppe-Seyler, F. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.07.007 · Cited by 457
Metadata
- Authors
- Martinez-Zapien, D., Ruiz, F. X., Poirson, J., Mitschler, A., Ramirez, J., Forster, A., Cousido-Siah, A., Masson, M., Pol, S. V., Podjarny, A., Travé, G., & Zanier, K.
- Venue
- Nature
- Published
- 2016-01-20
- Volume
- 529
- Issue
- 7587
- Pages
- 541-545
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2262285906
- Cited by
- 483
- References
- 39
- FWCI
- 17.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.